Age-related differences in glycaemic control in diabetes Elizabeth SelvinChristina M. Parrinello Commentary 05 October 2013 Pages: 2549 - 2551
Glucose-stimulated insulin secretion: the hierarchy of its multiple cellular and subcellular mechanisms Paolo MedaFrans Schuit Commentary 11 October 2013 Pages: 2552 - 2555
Prediction of type 2 diabetes in women with a history of gestational diabetes using a genetic risk score Soo Heon KwakSung Hee ChoiHak C. Jang Article 22 September 2013 Pages: 2556 - 2563
Immune cell-mediated inflammation and the early improvements in glucose metabolism after gastric banding surgery Katherine SamarasAlexander ViardotReginald V. Lord Article 13 September 2013 Pages: 2564 - 2572
Start of insulin therapy in patients with type 2 diabetes mellitus promotes the influx of macrophages into subcutaneous adipose tissue H. J. JansenR. StienstraC. J. Tack Article 25 September 2013 Pages: 2573 - 2581
Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised trial F. J. Lavalle-GonzálezA. JanuszewiczG. Meininger Article Open access 13 September 2013 Pages: 2582 - 2592
Age at type 2 diabetes onset and glycaemic control: results from the National Health and Nutrition Examination Survey (NHANES) 2005–2010 Seth A. BerkowitzJames B. MeigsDeborah J. Wexler Article 01 September 2013 Pages: 2593 - 2600
Mortality trends in patients with and without diabetes in Ontario, Canada and the UK from 1996 to 2009: a population-based study M. LindL. A. Garcia-RodriguezL. L. Lipscombe Article 11 October 2013 Pages: 2601 - 2608
Mutations in KCNJ11 are associated with the development of autosomal dominant, early-onset type 2 diabetes Limei LiuKazuaki NagashimaKunsan Xiang Article 10 September 2013 Pages: 2609 - 2618
Trans-ethnic fine mapping identifies a novel independent locus at the 3′ end of CDKAL1 and novel variants of several susceptibility loci for type 2 diabetes in a Han Chinese population Jane Z. KuoWayne Huey-Herng SheuYii-Der I. Chen Article Open access 08 September 2013 Pages: 2619 - 2628
Glucose principally regulates insulin secretion in mouse islets by controlling the numbers of granule fusion events per cell Jiun T. LowJustin M. MitchellPeter Thorn Article Open access 01 September 2013 Pages: 2629 - 2637
Pathological endoplasmic reticulum stress mediated by the IRE1 pathway contributes to pre-insulitic beta cell apoptosis in a virus-induced rat model of type 1 diabetes Chaoxing YangPhilip diIorioRita Bortell Article 13 September 2013 Pages: 2638 - 2646
Mouse beta cell proliferation is inhibited by thymidine analogue labelling Mark Van de CasteeleYing CaiHarry Heimberg Article 13 September 2013 Pages: 2647 - 2650
Alternative splicing and differential expression of the islet autoantigen IGRP between pancreas and thymus contributes to immunogenicity of pancreatic islets but not diabetogenicity in humans V. Martijn de JongJoana R. F. AbreuBart O. Roep Article 13 September 2013 Pages: 2651 - 2658
The CD19 signalling molecule is elevated in NOD mice and controls type 1 diabetes development Alexandra I. ZieglerMelanie A. Le PageRobyn M. Slattery Article 08 September 2013 Pages: 2659 - 2668
Imaging dynamics of CD11c+ cells and Foxp3+ cells in progressive autoimmune insulitis in the NOD mouse model of type 1 diabetes Anja Schmidt-ChristensenLisbeth HansenDan Holmberg Article 21 August 2013 Pages: 2669 - 2678
Exaggerated release and preserved insulinotropic action of glucagon-like peptide-1 underlie insulin hypersecretion in glucose-tolerant individuals after Roux-en-Y gastric bypass Carsten DirksenKirstine N. Bojsen-MøllerSten Madsbad Article 19 September 2013 Pages: 2679 - 2687
Oligopeptides stimulate glucagon-like peptide-1 secretion in mice through proton-coupled uptake and the calcium-sensing receptor Eleftheria DiakogiannakiRamona PaisFrank Reimann Article Open access 18 September 2013 Pages: 2688 - 2696
Ceramide accumulation in L6 skeletal muscle cells due to increased activity of ceramide synthase isoforms has opposing effects on insulin action to those caused by palmitate treatment Georgia FrangioudakisBarbara DiakanastasisCarsten Schmitz-Peiffer Short Communication 29 August 2013 Pages: 2697 - 2701
Latanoprost effectively ameliorates glucose and lipid disorders in db/db and ob/ob mice Gaihong WangXing XuXu Shen Article 29 August 2013 Pages: 2702 - 2712
PREP1 deficiency downregulates hepatic lipogenesis and attenuates steatohepatitis in mice Francesco OrienteSerena CabaroFrancesco Beguinot Article 20 September 2013 Pages: 2713 - 2722
Txnip contributes to impaired glucose tolerance by upregulating the expression of genes involved in hepatic gluconeogenesis in mice Seong Ho JoMi Young KimYong Ho Ahn Article 14 September 2013 Pages: 2723 - 2732
Catalase activity, allelic variations in the catalase gene and risk of kidney complications in patients with type 1 diabetes Kamel MohammediThiago A. PatenteGilberto Velho Article 21 September 2013 Pages: 2733 - 2742
Matrix metalloproteinase-10 plays an active role in microvascular complications in type 1 diabetic patients Marta ToniJosé HermidaNieves Díez Article 27 September 2013 Pages: 2743 - 2752
Longitudinal changes in insulin sensitivity and beta cell function between women with and without a history of gestational diabetes mellitus Anny H. XiangMiwa TakayanagiThomas A. Buchanan Article 13 September 2013 Pages: 2753 - 2760
Objectively assessed sedentary time and type 2 diabetes mellitus: a case–control study Mark HamerSophie BostockAndrew Steptoe Research Letter Open access 27 September 2013 Pages: 2761 - 2762
Proton pump inhibitors and nitric oxide mechanisms in type 2 diabetes Jonas T. C. Sertorio Letter 19 September 2013 Pages: 2763 - 2764
RETRACTED ARTICLE: Mortality trends in patients with and without diabetes in Ontario, Canada and the UK from 1996 to 2009: a population-based study M. LindL. A. Garcia-RodriguezL. L. Lipscombe Retraction Note 22 June 2013 Pages: 2765 - 2765